THE CHILDREN'S MEDICAL CENTER CORPORATION;DOMPE FARMACEUTICI S.P.A.
发明人:
Paolo FIORINA,Roberto BASSI,Andrea VERGANI,Marcello ALLEGRETTI
申请号：
US16338834
公开号：
US20190224148A1
申请日:
2017.10.03
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Embodiments herein disclose methods relating to diabetic nephropathy (DN)； methods for preventing the onset and also for preventing the progressing of DN, as well as the treatment of DN in diabetic subjects comprising administering reparixin and/or ladarixin which are inhibitors of CXCL8 receptor CXCR1 and CXCR2 activation.
